STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 3/30/2026
Summary
The White House has drafted legislative text for its drug pricing policy and is sharing it with more than a dozen major pharmaceutical companies. The news also mentions Trump pushing drug pricing policy and Chinese biotech licensing.
Advertisement
Lindy Score Breakdown (V4.2)
5h
Age
1
Sources
from cluster
4
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier94% (0.5^4/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Biogen lupus drug improves skin clearance in mid-stage study
Stat News • Today
STAT+: Early signs of Alzheimer’s often go undetected. These researchers want to change that
Stat News • Today
STAT+: The omnipresent power of health care jobs
Stat News • Today
Opinion: STAT+: Washington is on the verge of true PBM reform
Stat News • Today
STAT+: Health care jobs growth is stagnating at the biggest for-profit firms
Stat News • Today
Lead still raises risk of heart disease, years after exposure, study warns
Stat News • Today
7 big challenges for the next CDC director
Stat News • Today
Opinion: Remembering public health pioneer Barry Bloom: a scientist, a mentor, a mensch
Stat News • Today
Raw dairy co. refutes connection to E. coli outbreak
Stat News • Today